Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression

The alteration of glucose metabolism, through increased uptake of glucose and glutamine addiction, is essential to cancer cell growth and invasion. Increased flux of glucose through the Hexosamine Biosynthetic Pathway (HBP) drives increased cellular O-GlcNAcylation (hyper-O-GlcNAcylation) and contributes to cancer progression by regulating key oncogenes. However, the association between hyper-O-GlcNAcylation and activation of these oncogenes remains poorly characterized. Here, we implement a qualitative modeling framework to analyze the role of the Biological Regulatory Network in HBP activation and its potential effects on key oncogenes. Experimental observations are encoded in a temporal language format and model checking is applied to infer the model parameters and qualitative model construction. Using this model, we discover step-wise genetic alterations that promote cancer development and invasion due to an increase in glycolytic flux, and reveal critical trajectories involved in cancer progression. We compute delay constraints to reveal important associations between the production and degradation rates of proteins. O-linked N-acetylglucosamine transferase (OGT), an enzyme used for addition of O-GlcNAc during O-GlcNAcylation, is identified as a key regulator to promote oncogenesis in a feedback mechanism through the stabilization of c-Myc. Silencing of the OGT and c-Myc loop decreases glycolytic flux and leads to programmed cell death. Results of network analyses also identify a significant cycle that highlights the role of p53-Mdm2 circuit oscillations in cancer recovery and homeostasis. Together, our findings suggest that the OGT and c-Myc feedback loop is critical in tumor progression, and targeting these mediators may provide a mechanism-based therapeutic approach to regulate hyper-O-GlcNAcylation in human cancer.

[1]  Hidde de Jong,et al.  Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..

[2]  Thomas Mestl,et al.  FEEDBACK LOOPS, STABILITY AND MULTISTATIONARITY IN DYNAMICAL SYSTEMS , 1995 .

[3]  F. Schreiber,et al.  Centrality Analysis Methods for Biological Networks and Their Application to Gene Regulatory Networks , 2008, Gene regulation and systems biology.

[4]  O Mason,et al.  Graph theory and networks in Biology. , 2006, IET systems biology.

[5]  Wengong Yu,et al.  O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. , 2011, Biochimica et biophysica acta.

[6]  D. Vocadlo,et al.  Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells* , 2013, The Journal of Biological Chemistry.

[7]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[8]  W. Yang,et al.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability , 2006, Nature Cell Biology.

[9]  O. Warburg On respiratory impairment in cancer cells. , 1956, Science.

[10]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[11]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[12]  Thomas A. Henzinger,et al.  HYTECH: a model checker for hybrid systems , 1997, International Journal on Software Tools for Technology Transfer.

[13]  J. Comet,et al.  The SMBioNet Method for Discovering Models of Gene Regulatory Networks , 2009 .

[14]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[15]  M. Bryś,et al.  Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. , 2012, Clinical laboratory.

[16]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[17]  Galit Lahav,et al.  Oscillations by the p53-Mdm2 feedback loop. , 2008, Advances in experimental medicine and biology.

[18]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[19]  John J Tyson,et al.  Monitoring p53's pulse , 2004, Nature Genetics.

[20]  Piero Fariselli,et al.  Blurring contact maps of thousands of proteins: what we can learn by reconstructing 3D structure , 2011, BioData Mining.

[21]  A. Gartel,et al.  Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.

[22]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[23]  Robert H. Costa,et al.  Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators , 2004, Molecular and Cellular Biology.

[24]  Guy Karlebach,et al.  Modelling and analysis of gene regulatory networks , 2008, Nature Reviews Molecular Cell Biology.

[25]  B. Gary,et al.  Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer , 2014, PloS one.

[26]  Nobuyuki Tanaka,et al.  p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation , 2008, Nature Cell Biology.

[27]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[28]  T. Lefebvre,et al.  O-GlcNAcylation: A New Cancer Hallmark? , 2013, Front. Endocrinol..

[29]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[30]  R. Costa,et al.  Recruitment of p 300 / CBP Coactivators for Phosphorylation-Dependent Requires Binding of Cdk-Cyclin Complexes Forkhead Box M 1 B Transcriptional Activity , 2004 .

[31]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[32]  A. Levine,et al.  Gain of function mutations in p53 , 1993, Nature Genetics.

[33]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[34]  G. Sethi,et al.  Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1 , 2010, Oncogene.

[35]  A. Mercurio,et al.  ERβ regulation of NF-κB activation in prostate cancer is mediated by HIF-1 , 2015, Oncotarget.

[36]  Xiaoyong Yang,et al.  O-GlcNAc signaling in cancer metabolism and epigenetics. , 2015, Cancer letters.

[37]  U. Sauer,et al.  Coordination of microbial metabolism , 2014, Nature Reviews Microbiology.

[38]  N. Tanaka,et al.  Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification , 2009, Proceedings of the National Academy of Sciences.

[39]  Sung Soo Kim,et al.  Cancer cell metabolism: implications for therapeutic targets , 2013, Experimental & Molecular Medicine.

[40]  G. Hart,et al.  Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.

[41]  G. Hart,et al.  O-GlcNAc signaling: a metabolic link between diabetes and cancer? , 2010, Trends in biochemical sciences.

[42]  Michael Karin,et al.  NF-kB as a Critical Link Between Inflammation and Cancer , 2009 .

[43]  A. Thotakura,et al.  Cancer: NF-κB regulates energy metabolism. , 2012, The international journal of biochemistry & cell biology.

[44]  M. Pall Gene-amplification model of carcinogenesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Reginato,et al.  mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer , 2015, Molecular Cancer Research.

[46]  A. Puzio-Kuter,et al.  The Role of p53 in Metabolic Regulation. , 2011, Genes & cancer.

[47]  J. Collins,et al.  Construction of a genetic toggle switch in Escherichia coli , 2000, Nature.

[48]  Adrien Richard,et al.  Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. , 2004, Journal of theoretical biology.

[49]  Karen H. Vousden,et al.  Metabolic Regulation by p 53 Family Members , 2013 .

[50]  Youn Wha Kim,et al.  Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. , 2012, Human pathology.

[51]  M. Birnbaum,et al.  The role of FoxO in the regulation of metabolism , 2008, Oncogene.

[52]  Adrien Richard,et al.  Formal Methods for Modeling Biological Regulatory Networks , 2006 .

[53]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[54]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[55]  R. Ahmad,et al.  Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients , 2015, Oncology reports.

[56]  Feng Han,et al.  Tumor and Stem Cell Biology Cancer Research GlcNAcylation Plays an Essential Role in Breast Cancer Metastasis , 2010 .

[57]  Qianqian Zhu,et al.  O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation , 2012, Medical Oncology.

[58]  Uri Alon,et al.  Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.

[59]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[60]  Marco Pistore,et al.  NuSMV 2: An OpenSource Tool for Symbolic Model Checking , 2002, CAV.

[61]  M. Kaufman,et al.  From structure to dynamics: frequency tuning in the p53-Mdm2 network I. Logical approach. , 2009, Journal of theoretical biology.

[62]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[63]  G. Parker,et al.  Regulation of Akt signaling by O-GlcNAc in euglycemia. , 2008, American journal of physiology. Endocrinology and metabolism.

[64]  D. Burk,et al.  On respiratory impairment in cancer cells. , 1956, Science.

[65]  R. Thomas,et al.  Boolean formalization of genetic control circuits. , 1973, Journal of theoretical biology.

[66]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[67]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[68]  Benno Schwikowski,et al.  Graph-based methods for analysing networks in cell biology , 2006, Briefings Bioinform..

[69]  W. Dias,et al.  O-GlcNAcylation: The Sweet Side of the Cancer , 2014, Front. Oncol..

[70]  R. Thomas,et al.  Logical analysis of systems comprising feedback loops. , 1978, Journal of theoretical biology.

[71]  M. Bryś,et al.  Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations. , 2012, Ginekologia polska.

[72]  R. Moreno-Sánchez,et al.  Dual regulation of energy metabolism by p53 in human cervix and breast cancer cells. , 2015, Biochimica et biophysica acta.

[73]  U Alon,et al.  Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  T. Soussi,et al.  TP53: an oncogene in disguise , 2015, Cell Death and Differentiation.

[75]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[76]  Didier Lime,et al.  Hybrid Modelling and Dynamical Analysis of Gene Regulatory Networks with Delays , 2007, Complexus.

[77]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[78]  M. Bryś,et al.  Gene expression of O-GlcNAc cycling enzymes in human breast cancers , 2011, Clinical and Experimental Medicine.

[79]  Franck Delaplace,et al.  Semantics of Biological Regulatory Networks , 2007, Electron. Notes Theor. Comput. Sci..

[80]  Michael Naumann,et al.  Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention , 2012, BMC Systems Biology.

[81]  F. A. La Rosa,et al.  Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors , 1994, Molecular and cellular biology.

[82]  Thomas A. Henzinger,et al.  HYTECH: A Model Checker for Hybrid Systems , 1997, CAV.

[83]  M. Reginato,et al.  Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis* , 2012, The Journal of Biological Chemistry.

[84]  K. Vosseller,et al.  O-GlcNAc in cancer biology , 2013, Amino Acids.

[85]  Jamil Ahmad,et al.  A parallel approach for accelerated parameter identification of Gene Regulatory Networks , 2014, IWBBIO.

[86]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 (HIF-1) Pathway , 2007, Science's STKE.

[87]  Jing Zhao,et al.  Insights into the pathogenesis of axial spondyloarthropathy from network and pathway analysis , 2012, BMC Systems Biology.

[88]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[89]  P. Pelicci,et al.  Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging , 2013, Aging cell.

[90]  Jamil Ahmad,et al.  On the modelling and analysis of the regulatory network of dengue virus pathogenesis and clearance , 2014, Comput. Biol. Chem..

[91]  M. Disis Immune regulation of cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[92]  U. Niazi,et al.  Formal Modeling and Analysis of the MAL-Associated Biological Regulatory Network: Insight into Cerebral Malaria , 2012, PloS one.

[93]  Karen H. Vousden,et al.  Metabolic regulation by p53 , 2011, Journal of Molecular Medicine.

[94]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[95]  N. Perkins Achieving transcriptional specificity with nf-κb , 1997 .

[96]  René Thomas Regulatory networks seen as asynchronous automata: A logical description , 1991 .

[97]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[98]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[99]  O. Warburg On the origin of cancer cells. , 1956, Science.

[100]  D. E. Atkinson,et al.  Biological feedback control at the molecular level. , 1965, Science.

[101]  Stanley Wasserman,et al.  Social Network Analysis: Methods and Applications , 1994, Structural analysis in the social sciences.

[102]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[103]  Flore Kruiswijk,et al.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill , 2015, Nature Reviews Molecular Cell Biology.

[104]  O. Warburg,et al.  Über die Oxydationen in lebenden Zellen nach Versuchen am Seeigelei , 1910 .

[105]  V. Potter The biochemical approach to the cancer problem. , 1958, Federation proceedings.

[106]  A. Levine,et al.  Proliferation and tissue remodeling in cancer: the hallmarks revisited , 2012, Cell Death and Disease.

[107]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[108]  I. Mills,et al.  O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. , 2013, Cancer research.

[109]  R. Thomas,et al.  Dynamical behaviour of biological regulatory networks--II. Immunity control in bacteriophage lambda. , 1995, Bulletin of mathematical biology.

[110]  Carlos Cordon-Cardo,et al.  At the Crossroads of Inflammation and Tumorigenesis , 1999, The Journal of experimental medicine.

[111]  Jamil Ahmad Modélisation hybride et analyse des dynamiques des réseaux de régulations biologiques en tenant compte des délais , 2009 .

[112]  Aurélien Naldi,et al.  Logical modelling of gene regulatory networks with GINsim. , 2012, Methods in molecular biology.

[113]  T. Issad,et al.  O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity , 2008, Trends in Endocrinology & Metabolism.

[114]  Chi V. Dang,et al.  The interplay between MYC and HIF in cancer , 2008, Nature Reviews Cancer.

[115]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[116]  Reinhard Schneider,et al.  Using graph theory to analyze biological networks , 2011, BioData Mining.

[117]  P. Ernst,et al.  Review article: the role of inflammation in the pathogenesis of gastric cancer , 1999, Alimentary pharmacology & therapeutics.

[118]  René Thomas,et al.  Logical identification of all steady states: The concept of feedback loop characteristic states , 1993 .

[119]  R. Gillies,et al.  Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. , 2015, Cancer research.

[120]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.